Zobrazeno 1 - 10
of 151
pro vyhledávání: '"Ye, Chen"'
Publikováno v:
Expert Review of Anticancer Therapy. 22:1349-1355
The present study explores an extremely rare disease, thymic mucosa-associated lymphoid tissue (MALT) lymphoma, for its characteristics and prognostic factors by analyzing the Surveillance, Epidemiology, and End Results (SEER) database.From 2000 to 2
Autor:
Si-Ye Chen, Guang-Yi Sun, Yu Tang, Hao Jing, Yong-Wen Song, Jing Jin, Yue-Ping Liu, Xu-Ran Zhao, Yu-Chun Song, Bo Chen, Shu-Nan Qi, Yuan Tang, Ning-Ning Lu, Ning Li, Hui Fang, Ye-Xiong Li, Shu-Lian Wang
Publikováno v:
European Journal of Cancer. 174:153-164
To investigate the appropriate timing of radiotherapy (RT) after mastectomy and adjuvant chemotherapy for women with high-risk breast cancer.Post hoc analyses of 584 patients with stage II and III breast cancer from a randomised controlled clinical t
Autor:
Yu-Wen Zhou, Qing-Fang Li, Yue-Yun Chen, Kai Wang, Dan Pu, Xiao-Rong Chen, Chun-Hong Li, Li Jiang, Yan Wang, Qiu Li, Yu Yang, Hong-Feng Gou, Feng Bi, Ji-Yan Liu, Ye Chen, Meng Qiu
Publikováno v:
European Journal of Surgical Oncology. 48:1559-1566
The aim of the study was to comprehensively understand the combined hepatocellular and cholangiocarcinoma (CHC) and develop a nomogram for prognostic prediction of CHC.Data were collected from the Surveillance, Epidemiology and End Results (SEER) dat
Autor:
Hongxi Zhang, Kuiyuan Liu, Ruicheng Ba, Zelin Zhang, Yi Zhang, Ye Chen, Weizhong Gu, Zhipeng Shen, Qiang Shu, Junfen Fu, Dan Wu
Publikováno v:
Neuro-Oncology.
BackgroundGliomas are the most common type of central nervous system tumors in children, and the combination of histological and molecular classification is essential for prognosis and treatment. Here, we proposed a newly developed microstructural ma
Autor:
Jiamei Fu, J. Li, Chen Na, Zhiyuan Jiang, Xiaonan Yin, Ye Chen, Yanhong Ji, Xiaolan Su, Hongxin Deng, Lei Dai, Meng Qiu, Wei Huang, Bo Zhang, Chao Fang, Yuan Yin, Yang Li
Publikováno v:
Cancer Letters. 525:55-66
The members of the solute carrier (SLC) superfamily are vital membrane transporters in human cells. In the present study, we determine the expression and function of SLC5 family members in colorectal cancer (CRC). Expression analysis based on The Can
Publikováno v:
Cancer Management and Research
The increasingly widespread use of immunohistochemistry and next-generation sequencing (NGS) in the detection of microsatellite instability (MSI) and DNA mismatch repair (MMR) status has led to the observation of various unusual tumour types that exh
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Cancer Medicine, Vol 10, Iss 16, Pp 5415-5428 (2021)
Purpose To discuss whether the dome or anterior wall of bladder adenocarcinoma (BAC) should be classified into urachal carcinoma (UrC) and the relationship of primary tumor location (PTL) as well as treatment with survival. Methods Surveillance, Epid
Autor:
Zhiqing, Wang, Zhi, Wang, Ying, Wang, Jianhua, Wu, Zonglin, Yu, Chudi, Chen, Junsheng, Chen, Baoping, Wu, Ye, Chen
Publikováno v:
Frontiers in Oncology. 12
Peutz-Jeghers syndrome (PJS) is an autosomal dominant inherited disorder associated with a predisposition to a variety of cancers. Previous studies that have evaluated the cancer spectrum and risk of this rare disease have primarily been based on sma
Autor:
Guoming Shi, Xiaoyong Huang, Tianfu Wen, Tianqiang Song, Ming Kuang, Haibo Mou, Lequn Bao, Haitao Zhao, Hong Zhao, Xielin Feng, Bixiang Zhang, Tao Peng, Yubao Zhang, Xiangcheng Li, Hongsheng Yu, Yu Cao, Yang Luo, Ye Chen, Mingxia Chen, Jia Fan, Jian Zhou
Publikováno v:
Cancer Research. 83:CT153-CT153
Background: Pemigatinib is a selective FGFR inhibitor that showed effectiveness and tolerability in patients with cholangiocarcinoma (CAA) with FGFR2 fusion or rearrangement. Data from prior data cutoffs (primary: Jan 29th, 2021; initial update: Dec
Autor:
Meng Qiu, Dan Pu, Qiu Li, Ye Chen, Feng Bi, Hongfeng Gou, Yuwen Zhou, Yi-Xiu Long, Jia-Yan Huang, Ji-Yan Liu
Publikováno v:
Cancer Medicine
Cancer Medicine, Vol 10, Iss 10, Pp 3388-3402 (2021)
Cancer Medicine, Vol 10, Iss 10, Pp 3388-3402 (2021)
Background To compare the efficacy of first‐line bevacizumab plus chemotherapy with cetuximab plus chemotherapy based on the stratification of metastatic colorectal cancer (mCRC) patients with mucinous adenocarcinoma (MA) or mucinous component (MC)